Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Shineway Pharmaceutical Group Limited ( (HK:2877) ) just unveiled an update.
China Shineway Pharmaceutical Group Limited reported a significant decrease in turnover for the first quarter of 2025, with a total revenue of RMB761 million, marking a 31.9% decline compared to the same period in 2024. The company experienced downturns across its product lines, with injection products, soft capsules, granules, and TCM formula granules all seeing substantial reductions in sales, impacting the company’s market positioning and potentially affecting stakeholder confidence.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the production of various pharmaceutical products, including injection products, soft capsules, granules, and traditional Chinese medicine (TCM) formula granules.
Average Trading Volume: 1,353,123
Technical Sentiment Signal: Hold
Current Market Cap: HK$5.56B
Find detailed analytics on 2877 stock on TipRanks’ Stock Analysis page.